At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intra-articular Treatment With MEN16132 in Patients With Symptomatic Primary Osteoarthritis of the Knee: A Randomized, Multi-centre, Double Blind, Placebo Controlled, Five Parallel Group, Dose Finding Study
In Brief
A Phase 2 clinical trial evaluating MEN16132 - 0.125 mg, MEN16132 - 0.25 mg, and 2 other interventions for Osteoarthritis, Knee. Completed, enrolled 423 participants across 23 sites in 4 countries.
Detailed Summary
The purpose of this study is to determine whether intra-articular (knee joint) administration of MEN16132 is effective reducing the pain from knee osteoarthritis.
Study Details
Timeline
Interventions
Intra-articular administration of two low doses of MEN16132 at 2-week interval.
Intra-articular injection of two intermediate doses of MEN16132 at 2-week interval
Intra-articular injection of two high doses of MEN16132 at 2-week interval
Single intra-articular injection of one high dose of MEN16132, followed by one dose of placebo at 2-week interval
Intra-articular injection of 2 doses of Placebo control at 2-week interval